Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13574291 | 0.95 | SMN1; SMN2 (0.35) | KMT2ASMN1; SMN2PSMB8PSMB5 | |
| SCHEMBL1603588 | 0.93 | SMN1; SMN2 (0.38) | KMT2ASMN1; SMN2PSMB8PSMB5 | |
| SCHEMBL2608502 | 0.89 | LMNA (0.34) | PSMB8PSMB5MGLL | |
| SCHEMBL22777675 | 0.88 | SMN1; SMN2 (0.36) | KMT2ASMN1; SMN2PSMB8PSMB5ALOX12 | |
| SCHEMBL34383 | 0.88 | SMN1; SMN2 (0.36) | KMT2ASMN1; SMN2PSMB8PSMB5ALOX12 | |
| SCHEMBL290461 | 0.88 | SMN1; SMN2 (0.40) | KMT2ASMN1; SMN2PSMB8PSMB5ALOX12 | |
| SCHEMBL905722 | 0.86 | SMN1; SMN2 (0.42) | KMT2ASMN1; SMN2PSMB8PSMB5ALOX12 | |
| SCHEMBL379163 | 0.86 | SMN1; SMN2 (0.42) | KMT2ASMN1; SMN2PSMB8PSMB5ALOX12 | |
| SCHEMBL4960230 | 0.86 | SMN1; SMN2 (0.42) | KMT2ASMN1; SMN2PSMB8PSMB5ALOX12 | |
| SCHEMBL1870550 | 0.86 | SMN1; SMN2 (0.42) | KMT2ASMN1; SMN2PSMB8PSMB5ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190309171-A1 | MULTIMERIC PROTECTED FLUORESCENT REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2019-10-10 | — | — | US | disclosed |
| US-20120231459-A1 | CHEMILUMINESCENT PROBES FOR MULTIPLEX MOLECULAR QUANTIFICATION AND USES THEREOF | GEN-PROBE INCORPORATED (US) | 2012-09-13 | — | — | US | disclosed |
| US-20110082279-A1 | Chemiluminescent Compounds | GEN-PROBE INCORPORATED (US) | 2011-04-07 | — | — | US | disclosed |
| EP-1658503-B1 | CHEMILUMINESCENT COMPOUNDS | MOLECULAR LIGHT TECH RES LTD (GB) | 2009-11-18 | — | — | EP | disclosed |
| US-20070166759-A1 | Chemiluminescent compounds | GEN-PROBE CARDIFF, LTD. (GB) | 2007-07-19 | — | — | US | disclosed |
| EP-1658503-A1 | CHEMILUMINESCENT COMPOUNDS | Molecular Light Technology Research Limited (GB) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005022161-A1 | CHEMILUMINESCENT COMPOUNDS | MOLECULAR LIGHT TECHNOLOGY RESEARCH LIMITED (GB) | 2005-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166759-A1 | Chemiluminescent compounds | CBR3, CBR1, LTC4S | KMT2A 3854/4885SMN1; SMN2 4725/4885PSMB8 4466/4885 |
| US-20120231459-A1 | CHEMILUMINESCENT PROBES FOR MULTIPLEX MOLECULAR QUANTIFICATION AND USES THEREOF | HMBS, NOD1, DCLRE1B | KMT2A 3735/4885SMN1; SMN2 4855/4885PSMB8 4014/4885 |
| US-20110082279-A1 | Chemiluminescent Compounds | CBR3, LTC4S, CBR1 | KMT2A 3896/4885SMN1; SMN2 4695/4885PSMB8 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.